Dentsply Sirona Earnings Preview

Dentsply Sirona (NASDAQ:XRAY) will release its quarterly earnings report on Thursday, 2026-02-26. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Dentsply Sirona to report an earnings per share (EPS) of $0.28.

Dentsply Sirona bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Earnings History Snapshot

In the previous earnings release, the company missed EPS by $0.08, leading to a 1.45% increase in the share price the following trading session.

Here's a look at Dentsply Sirona's past performance and the resulting price change:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.45	0.50	0.30	0.43
EPS Actual	0.37	0.52	0.43	0.26
Price Change %	1.45	-2.04	-0.63	-3.50

Stock Performance

Shares of Dentsply Sirona were trading at $13.14 as of February 24. Over the last 52-week period, shares are down 26.56%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Get to Know Dentsply Sirona Better

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

Dentsply Sirona's Economic Impact: An Analysis

Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.

Decline in Revenue: Over the 3 months period, Dentsply Sirona faced challenges, resulting in a decline of approximately -4.94% in revenue growth as of 30 September, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.

Net Margin: Dentsply Sirona's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -47.23%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Dentsply Sirona's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -24.84%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Dentsply Sirona's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -7.29%, the company may encounter challenges in delivering satisfactory returns from its assets.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.68.

To track all earnings releases for Dentsply Sirona visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.